|COMPOUND||INDICATION||PRE – CLINICAL||CLINICAL|
Invasive Pulmonary Aspergillosis (IPA)
Allergic Bronchopulmonary Aspergillosis (ABPA)
* We hold rights to develop this molecule pursuant to an agreement with a drug-design firm.
We are developing a novel inhalation therapeutic for treating certain fungal infections in immunocompromised patients.